On 2025-05-08, Revelation Biosciences, Inc. (REVB) announced earnings per share of $-2.11 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-6.88.
The next expected annoucement date for quarterly earnings is 2025-08-08, with an average estimated earnings per share of $-1.99 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-6.88 | $-2.11 |
| 2025-03-06 | 2024-12-31 | $-3.20 | $-4.98 |
| 2024-11-08 | 2024-09-30 | $-45.44 | $-13.44 |
| 2024-08-09 | 2024-06-30 | $-28.96 | $-24.64 |
| 2024-05-10 | 2024-03-31 | $-86.24 | $-39.36 |
| 2024-03-22 | 2023-12-31 | $-175.04 | $-133.28 |
| 2023-11-09 | 2023-09-30 | $-144.14 | $-197.00 |
| 2023-08-11 | 2023-06-30 | $-158.56 | $-120.12 |
| 2023-05-22 | 2023-03-31 | $-312.31 | $-245.05 |
| 2023-03-30 | 2022-12-31 | $-840.84 | $-850.45 |
| 2022-11-10 | 2022-09-30 | $-1512.00 | $-1008.00 |
| 2022-08-15 | 2022-06-30 | $-2352.00 | $-2016.00 |
| 2022-05-16 | 2022-03-31 | $-2352.00 | $-7896.01 |